Respiratory Syncytial Virus (RSV)

Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age

A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women

A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus

TARSILA Real-World Evidence Study

Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Systems Biological Analysis of Immune Responses to RSV Vaccine

Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

A Clinical Trial of SIBP-A16 Injection in Healthy Adults

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults.

Antibiotic Therapy in Viral Airway Infections

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease